ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma

High-dose methotrexate based chemotherapy(HD-MTX) improved outcome of primary central nervous system lymphoma(PCNSL), but the prognosis is still poor. Recent studies showing that Rituximab is very effective for systemic lymphoma, the role of Rituximab for PCNSL is unclear. 34 patients diagnosed PCNS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurooncol Adv
Hlavní autoři: Takezaki, Tatsuya, Ota, Kazutaka, Kuroda, Junichiro, Shinojima, Naoki, Takeshima, Yuki, Matsuura, Jin, Yamamoto, Takahiro, Makino, Keishi, Mukasa, Akitake
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Supplement Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699048/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.077
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky